首页> 外文期刊>Journal of bronchology & interventional pulmonology >Use of an Additional 19-G EBUS-TBNA Needle Increases the Diagnostic Yield of EBUS-TBNA
【24h】

Use of an Additional 19-G EBUS-TBNA Needle Increases the Diagnostic Yield of EBUS-TBNA

机译:使用额外的19克EBUS-TBNA针提高了EBUS-TBNA的诊断产量

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Although endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has an excellent diagnostic yield, there remain cases where the diagnosis is not obtained. We hypothesized that additional sampling with a 19-G EBUS-TBNA needle may increase diagnostic yield in a subset of cases where additional tissue sampling was required. Methods: Indications for use of me 19-G needle following 22-G sampling with rapid on-site cytologic examination were: (1) diagnostic uncertainty of the on-site cytopathol-ogist (eg, nondiagnostic, probable lymphoma, etc.), (2) non-small cell lung cancer with probable need for molecular genetic and/or PD-L1 testing, or (3) need for a larger tissue sample for consideration of inclusion in a research protocol. Results: A 19-G EBUS-TBNA needle was utilized following standard sampling with a 22-G needle in 48 patients (50 sites) during the same procedure. Although the diagnostic yield between the needles was equivalent, the concordance rate was only 83%. The 19-G determined a diagnosis hi 4 additional patients (8%) and provided additional histopathologic information in 6 other cases (12%). Conversely, in 3 cases (6%) diagnostic information was provided only by the 22-G needle. Compared with 22-G EBUS-TBNA alone, sampling with both the 22- and 19-G EBUS needles resulted in an increase in diagnostic yield from 92% to 99% (P = 0.045) and a number needed to sample of 13 patients to provide one additional diagnosis. There were no significant complications. Conclusion: In select cases where additional tissue may be needed, sampling with a 19-G EBUS needle following standard aspiration with a 22-G needle results in an increase in diagnostic yield.
机译:背景:虽然胚胎超声引导的横向针刺(EBUS-TBNA)具有优异的诊断产量,但仍然存在未获得诊断的情况。我们假设具有19-g ebus-tbna针的额外取样可以增加所需额外组织采样的案例的子集中的诊断产量。方法:使用快速现场细胞学检查后22-G采样后使用ME 19-G针的适应症是:(1)现场细胞源性诊断的不确定度(例如,非诊断,可能的淋巴瘤等), (2)非小细胞肺癌具有可能的分子遗传遗传和/或PD-L1试验,或(3)需要较大的组织样本以考虑包含在研究方案中的包含。结果:在相同的手术期间,在48名患者(50个位点)中的22g针刺上用22g针进行标准取样,使用19g ebus-tbna针。虽然针与针之间的诊断产量相当,但一致性率仅为83%。 19-G确定了诊断HI 4额外的患者(8%)并在其他6例中提供了另外的组织病理学信息(12%)。相反,在3例(6%)仅由22-g针提供诊断信息。与单独的22-g EBUS-TBNA相比,用22-12-19g eBus针的取样导致诊断产量增加到92%至99%(p = 0.045),并为13名患者进行样品提供一个额外的诊断。没有显着的并发症。结论:在可能需要额外组织的选择情况下,用22g针针的标准抽吸伴随19-g ebus针采样,导致诊断产量的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号